Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial

Martin Schlumberger, Sophie Leboulleux, Bogdan Catargi, Désirèe Deandreis, Slimane Zerdoud, Stéphane Bardet, Daniéla Rusu, Yann Godbert, Camille Buffet, Claire Schvartz,

The Lancet Diabetes & Endocrinology · 2018 · 165 citations · 22 references

Concepts

References

22